Asia Pacific In-vitro Fertilization Market Forecast 2018-2026

Asia Pacific In-vitro Fertilization Market Forecast 2018-2026

KEY FINDINGS

The Asia-Pacific in-vitro fertilization (IVF) market is forecasted to rise with 12.68% CAGR over the estimated period of 2018-2026. The market is expected to hold much promise for the overall global IVF market, increasing its revenue from $xx million in 2017 to $xx million by the end of 2026.

MARKET INSIGHTS

The cost of IVF procedures is quite cheap in Asia-Pacific as compared to other regional markets. Hence the region is also being preferred by people all over the world for IVF treatments. Perhaps this is the reason why the Asia-Pacific IVF market is slated to showcase the highest CAGR increase over the forecast period as compared to other regional markets. Investments from private equity investors for further advancement in research and development in IVF techniques in this area are providing substantial growth opportunities for the market. However, in some of these Asia-Pacific countries, male infertility is considered as a social taboo which refrains them from using the IVF methods. Instead, they prefer to go for traditional treatments to solve this problem. These factors could possibly restrict the growth of the Asia-Pacific market in the coming years.

COMPETITIVE INSIGHTS

Halotech DNA, Thermo Fisher Scientific Inc, Auxogyn, Copper Surgical Inc, Ovascience, Vitrolife Ab, Irvine Scientific (Subsidiary Of Nippon Mining Holdings), Cook Medical Inc, Genea, Merck Serono, Andrology Solutions, Esco Micro Pte. Ltd, Ferring Pharmaceuticals, and Ivftech Aps are some of the top companies engaged in this market.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
2.5. Research Methodology
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Asia Pacific To Shows Great Promise Over The Forecast Period
3.2.2. Insurance Coverage For Ivf
3.2.3. Growth Of Medical Tourism
4. Market Dynamics
4.1. Market Definition
4.2. Drivers
4.2.1. Increasing Rate Of Infertility Across The Globe
4.2.2. Flexible Government Regulations For Fertility Tourism
4.2.3. Improved Surrogacy Laws
4.2.4. High Success Rates Of Advanced In-vitro Fertilization Treatments
4.3. Restraints
4.3.1. High Cost
4.3.2. Country Wise Regulatory Issues
4.4. Opportunities
4.4.1. Increasing Demand For Low-cost Procedures
4.4.2. Ivf Attracting Investments From Private Equity Investors
4.5. Challenges
4.5.1. Infertility Considered A Social Taboo Amongst Men
4.5.2. Traditional Treatments Used Widely As An Alternative To Ivf
4.5.2.1. Diet And Supplements
4.5.2.2. Acupuncture
4.5.2.3. Therapy
4.5.2.4. Qigong
5. Market By Product And Procedures
5.1. By Product
5.1.1. Reagents
5.1.2. Equipments
5.2. By Procedure
5.2.1. Intra Cytoplasmic Sperm Injection (Icsi)
5.2.2. Pre Implantation Genetic Diagnosis (Pgd)
5.2.3. Frozen Embryo Transfer/Replacement (Fet/Fer)
5.2.4. Others
6. Market By End-user
6.1. Fertility And Surgical Centers
6.2. Hospitals And Research Laboratories
6.3. Cryobanks
7. Key Analytics
7.1. Porter’s 5 Force Model
7.1.1. Threat Of New Entrants
7.1.2. Threat Of Substitute Products
7.1.3. Bargaining Power Of Buyers
7.1.4. Bargaining Power Of Suppliers
7.1.5. Intensity Of Competitive Rivalry
7.2. Value Chain Analysis
7.2.1. Raw Material Procurement
7.2.2. Manufacturing
7.2.3. Supply Logistics
7.2.4. Distribution Channels
7.2.5. End Users
7.3. Key Buying Criteria
7.3.1. Treatment Options
7.3.2. Quality Of Medical Procedures
7.3.3. Price Of Treatments
7.3.4. Shift Towards Medical Tourism
7.3.5. Reimbursement
7.4. Regulatory Framework
7.5. Investment Outlook
7.5.1. End-user Outlook
7.6. Vendor Landscape
7.7. Opportunity Matrix
8. Geographical Analysis
8.1. China
8.2. India
8.3. Japan
8.4. South Korea
8.5. Australia
8.6. Thailand
8.7. Rest Of Asia-pacific
9. Competitive Landscape
9.1. Market Share Analysis
9.1.1. Vitrolife
9.1.2. Cooper Surgical
9.1.3. Merck
9.1.4. Cook Medical
9.1.5. Ferring Pharmaceuticals
9.2. Top Winning Strategies
9.3. Company Profiles
9.3.1. Andrology Solutions
9.3.1.1. Overview
9.3.1.2. Product Portfolio
9.3.1.3. Scot Analysis
9.3.1.4. Strategic Analysis
9.3.2. Auxogyn
9.3.2.1. Overview
9.3.2.2. Products
9.3.2.3. Strategic Initiatives
9.3.2.4. Scot Analysis
9.3.2.5. Strategic Analysis
9.3.3. Cook Medical Inc
9.3.3.1. Overview
9.3.3.2. Product Portfolio
9.3.3.3. Strategic Initiatives
9.3.3.4. Scot Analy
9.3.3.5. Strategic Analysis
9.3.4. Copper Surgical Inc
9.3.4.1. Overview
9.3.4.2. Product Portfolio
9.3.4.3. Strategic Initiatives
9.3.4.4. Scot Analysis
9.3.4.5. Strategic Analysis
9.3.5. Esco Micro Pte. Ltd.
9.3.5.1. Overview
9.3.5.2. Product Portfolio
9.3.5.3. Strategic Initiatives
9.3.5.4. Scot Analysis
9.3.5.5. Strategic Analysis
9.3.6. Ferring Pharmaceuticals
9.3.6.1. Overview
9.3.6.2. Product Portfolio
9.3.6.3. Strategic Initiatives
9.3.6.4. Scot Analysis
9.3.6.5. Strategic Analysis
9.3.7. Genea
9.3.7.1. Overview
9.3.7.2. Product Portfolio
9.3.7.3. Strategic Initiatives
9.3.7.4. Scot Analysis
9.3.7.5. Strategic Analysis
9.3.8. Halotech Dna
9.3.8.1. Overview
9.3.8.2. Product Portfolio
9.3.8.3. Scot Analysis
9.3.8.4. Strategic Analysis
9.3.9. Irvine Scientific (Subsidiary Of Nippon Mining Holdings)
9.3.9.1. Overview
9.3.9.2. Product Portfolio
9.3.9.3. Strategic Initiatives
9.3.9.4. Scot Analysis
9.3.9.5. Strategic Analysis
9.3.10. Ivftech Aps
9.3.10.1. Overview
9.3.10.2. Product Portfolio
9.3.10.3. Scot Analysis
9.3.10.4. Strategic Analysis
9.3.11. Merck Serono
9.3.11.1. Overview
9.3.11.2. Product Portfolio
9.3.11.3. Strategic Initiatives
9.3.11.4. Scot Analysis
9.3.11.5. Strategic Analysis
9.3.12. Ovascience
9.3.12.1. Overview
9.3.12.2. Product Portfolio
9.3.12.3. Strategic Initiatives
9.3.12.4. Scot Analysis
9.3.12.5. Strategic Analysis
9.3.13. The Baker Company, Inc.
9.3.13.1. Overview
9.3.13.2. Product Portfolio
9.3.13.3. Scot Analysis
9.3.13.4. Strategic Analysis
9.3.14. Thermo Fisher Scientific Inc
9.3.14.1. Overview
9.3.14.2. Product Portfolio
9.3.14.3. Strategic Initiative
9.3.14.4. Scot Analysis
9.3.14.5. Strategic Analysis
9.3.15. Vitrolife Ab
9.3.15.1. Overview
9.3.15.2. Product Portfolio
9.3.15.3. Strategic Initiatives
9.3.15.4. Scot Analysis
9.3.15.5. Strategic Analysis
List Of Tables
Table 1 Asia Pacific In-vitro Fertilization Market By Country 2018-2026 ($ Million)
Table 2 Asia Pacific Ivf Market By Product And Procedures 2018-2026 ($ Million)
Table 3 Asia Pacific Ivf Market By Products 2018-2026 ($ Million)
Table 4 Asia Pacific Ivf Market By Procedure 2018-2026 ($ Million)
Table 5 Asia Pacific Ivf Market By End-user 2018-2026 ($ Million)
Table 6 Asia Pacific Ivf Market By Country 2018-2026 ($ Million)
List Of Figures
Figure 1 Asia Pacific In-vitro Fertilization Market By Procedure 2018-2026 ($ Million)
Figure 2 Asia Pacific Ivf Market 2018-2026 ($ Million)
Figure 3 Evolution Of Ivf Market
Figure 4 Asia Pacific Reagents Market 2018-2026 ($ Million)
Figure 5 Asia Pacific Equipments Market 2018-2026 ($ Million)
Figure 6 Asia Pacific Intra Cytoplasmic Sperm Injection (Icsi) Market 2018-2026 ($ Million)
Figure 7 Asia Pacific Pre-implantation Genetic Diagnosis (Pgd) Market 2018-2026 ($ Million)
Figure 8 Asia Pacific Frozen Embryo Transfer/Replacement (Fet/Fer) Market 2018-2026 ($ Million)
Figure 9 Asia Pacific Others Market 2018-2026 ($ Million)
Figure 10 Asia Pacific Fertility And Surgical Centers Market 2018-2026 ($ Million)
Figure 11 Asia Pacific Hospitals And Research Laboratories Market 2018-2026 ($ Million)
Figure 12 Asia Pacific Cryobanks Market 2018-2026 ($ Million)
Figure 13 Investment Proposition For Asia Pacific Ivf Market By End-user - 2017
Figure 14 China Ivf Market 2018-2026 ($ Million)
Figure 15 India Ivf Market 2018-2026 ($ Million)
Figure 16 Japan Ivf Market 2018-2026 ($ Million)
Figure 17 South Korea Ivf Market 2018-2026 ($ Million)
Figure 18 Australia Ivf Market 2018-2026 ($ Million)
Figure 19 Thailand Ivf Market 2018-2026 ($ Million)
Figure 20 Rest Of Asia-pacific Ivf Market 2018-2026 ($ Million)
Figure 21 Asia Pacific Ivf Market Share Of Major Companies – 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook